Study of Rituximab to Treat Chronic Renal Transplant Rejection

NCT00476164 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation
Graft Rejection
Immunosuppression

Interventions

DRUG: Rituximab
OTHER: Control arm

Sponsor

King's College London

Collaborators

[object Object]
[object Object]